Publication details
Post
-translational modifications regulate signalling by Ror1
| Basic information | |
|---|---|
| Original title: | Post -translational modifications regulate signalling by Ror1 |
| Authors: | Markéta Kaucká, Pavel Krejčí, Karla Plevová, Šárka Pavlová, Jiřina Procházková, Pavlína Janovská, Jana Valnohová, Alois Kozubík, Šárka Pospíšilová, Vítězslav Bryja |
| Further information | |
|---|---|
| Citation: | KAUCKÁ, Markéta, Pavel KREJČÍ, Karla PLEVOVÁ, Šárka PAVLOVÁ,
Jiřina PROCHÁZKOVÁ, Pavlína JANOVSKÁ, Jana VALNOHOVÁ, Alois
KOZUBÍK, Šárka POSPÍŠILOVÁ and Vítězslav BRYJA.
Post -translational modifications regulate signalling by Ror1
(Post -translational modifications regulate signalling by Ror1).
Acta Physiologica, Oxford: Blackwell Publishing, 2011, vol.
203, No 3, p. 351 -362. ISSN 1748 -1708.
doi:10.1111/j.1748 -1716.2011.02306.x.Export BibTeX |
| Original language: | English |
| Field: | Genetics and molecular biology |
| Type: | Article in Periodical |
| Keywords: | Ror1; posttranslational modifications; glycosylation; chronic lymphocytic leukemia |
Ror1 (receptor tyrosine kinase-like orphan receptor)is highly upregulated in B cells of patients with chronic lymphocytic leukaemia (CLL). Ror1 acts as the Wnt receptor in the non-canonical Wnt pathway. We demonstrate that Ror1 is extensively modified by N-linked glycosylation. Glycosylation produces several variants of Ror1 with electrophoretic migration of approx. 100, 115 and 130 kDa. Inhibition of glycosylation interferes with cell surface localization of the 130-kDa variant of Ror1 and prevents Ror1-induced formation of filopodia. Moreover, we show that 130-kDa Ror1 is mono-ubiquitinated. Furthermore, individual CLL patients show striking differences in the electrophoretic migration of Ror1, which correspond to the level of glycosylation. Our data show that Ror1 undergoes complex post-translational modifications by glycosylation and mono-ubiquitination. These modifications regulate Ror1 localization and signalling, and are highly variable among individual CLL patients. These may suggest that Ror1 signals only in a subset of CLL patients despite Ror1 levels are ubiquitously high in all CLL patients.
Related projects:
- Functional and molecular characteristics of cancer and normal stem cells - identification of targets for novel therapeutics and therapeutic strategies
- EMBO Young Investigator Programme
- Intercellular signalling in development and disease
- Novel pathway of FGFR3 signaling in achondroplasia
- Úloha komponent Wnt/PCP dráhy v patogenezi B lymfocytární chronické leukémie
- Úloha nekanonické Wnt signalizace v molekulární patogenezi chronické lymfocytární leukémie
- Molekulární základy FGFR3 signalingu v kostní dysplázii
- Molekulární mechanismy nekanonické Wnt signalizace v leukémii











